News

Codis Revolutionizes Spray Drying with New Global CDMO Services

Codis Revolutionizes Spray Drying with New Global CDMO Services

Codis Emerges as a New Leader in Global CDMO Services

Introducing a pioneering global CDMO that merges advanced spray drying and particle engineering technologies under a unified brand.

Formation and Specialization of Codis

Codis has recently launched as a prominent global Contract Development and Manufacturing Organization (CDMO). This innovative company specializes in commercial-scale spray drying and amorphous solid dispersions (ASD), bringing together industry expertise and cutting-edge technology.

Origins and Integration

The establishment of Codis is a significant milestone, resulting from the integration of two industry leaders: Particle Dynamics and the former spray drying facility previously operated by EUROAPI in Haverhill, UK. This strategic union combines years of resourcefulness and regulatory acumen, laying a solid foundation for future endeavors.

Service Offerings and Capabilities

With extensive facilities located in St. Louis, Seymour, and Haverhill, Codis stands out for its impressive output capabilities:

  • Annual output exceeding 5000 metric tons of spray drying capacity.
  • A diverse product portfolio featuring 30 distinct products catering to over 50 pharmaceutical customers worldwide.
  • A remarkable 30-year track record in navigating regulatory landscapes successfully.
  • Rigorous auditing and approval from six renowned international regulatory bodies.
  • A dedicated workforce of over 300 employees contributing to various aspects of operations.

Core Values and Strategic Direction

The guiding philosophy of Codis, as articulated by CEO Nicolas Fortin, emphasizes growth through scale, quality, and a broad-reaching global presence. With operations encompassing 40,000 m2 of state-of-the-art manufacturing space and multiple GMP-approved facilities, Codis is strategically positioned to expedite the path for pharmaceutical developers seeking to bring their innovations to market.

Expertise in Regulatory Compliance

Acquired from EUROAPI in mid-2025, the Haverhill site brings along a rich legacy of excellence in spray drying, continuous flow chemistry processes, and regulatory compliance. This pivotal facility also plays a crucial role as a leading manufacturer of Sevelamer, highlighting its capacity to support high-quality products that meet global regulatory standards.

The Codis Identity and Mission

The name Codis, which draws from the Latin word codex, meaning "law" or "system", encapsulates the company’s overarching commitment to compliance, reliability, and effective problem-solving for its global partners.

About Codis

Codis stands out in the CDMO landscape, specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and the manufacturing of finished dosage forms across pharmaceutical, consumer health, nutraceutical, and OTC sectors.

Key Strengths of Codis

Codis prides itself on delivering exceptional capabilities:

  • A substantial GMP spray drying capacity, among the largest in the industry.
  • A proven record of achieving regulatory approvals across prominent agencies such as the FDA, EMA, and PMDA.
  • Recognition as a trusted partner by top-tier pharmaceutical companies globally.

Frequently Asked Questions

What services does Codis provide as a CDMO?

Codis offers specialized services in commercial spray drying, amorphous solid dispersions, and particle engineering, catering to the pharmaceutical sector.

How was Codis formed?

Codis was formed through the integration of Particle Dynamics and the former EUROAPI facility in Haverhill, UK, combining extensive expertise and technology.

What is Codis’s manufacturing capacity?

Codis has an output capacity exceeding 5000 metric tons per year, demonstrating significant capability in commercial-scale production.

Where are Codis’s facilities located?

Codis operates facilities in St. Louis, Missouri, Seymour, Indiana, and Haverhill, UK, each equipped for advanced manufacturing processes.

What does Codis aim to achieve?

Codis aims to accelerate the development of pharmaceutical therapies, emphasizing quality, compliance, and global reach in its operations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 5

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading

Top 5 Most Recently Viewed Articles

Troilus Gold Corp. Expands Debt Financing to $1 Billion

Updated Category News Views 139

Troilus Gold Corp. Increases Debt Financing to $1 Billion Troilus Gold Corp. has announced an increase in its debt financing mandate from $700 million to a significant $1 billion. This update comes from the company as part of their plans to support the development of the Troilus Project, a major undertaking in the mining sector. Strengthening Market Confidence The...

Continue Reading
UWM Holdings Faces Legal Troubles, Shares Drop 35%

Updated Category News Views 17

A Hard Look at UWM Holdings' Legal Woes Well, here's a good one for the books. If you've been keeping an eye on UWM Holdings Corporation, you probably need no reminder of the rollercoaster they've been riding. Now, they've hit another snag—this time in the form of a class action lawsuit from some ticked-off investors. Cracks in the facade started to show after an...

Continue Reading
Apple iPhone 16 Sells Stopped in Indonesia Over Local Rules

Updated Category News Views 91

Apple iPhone 16 Sales Halted in Indonesia Apple Inc (NASDAQ: AAPL) finds itself facing a significant challenge in the Indonesian market as it cannot proceed with the sales of its latest iPhone 16 smartphones. This setback is largely due to Indonesia's stringent regulations that mandate smartphones sold in the country must include a minimum of 40% locally sourced...

Continue Reading
TrustCo Bank Corp NY Unveils New Dividend Strategy for Investors

Updated Category News Views 154

TrustCo Bank Corp NY Announces First Dividend of 2025 TrustCo Bank Corp NY (NASDAQ: TRST) has recently declared its quarterly cash dividend for 2025, reaffirming its commitment to shareholders. This was announced during a recent board meeting, where TrustCo's leadership showcased their dedication to ongoing shareholder value. Details of the Dividend Announcement The Board...

Continue Reading
Morgan Stanley's Recent Shareholder Notification Explained

Updated Category News Views 212

Understanding Morgan Stanley's Recent Shareholder Notification Morgan Stanley, a global leader in financial services, recently made headlines regarding an important shareholder notification concerning their financial stake in Solvay. This notification indicates that Morgan Stanley has crossed a significant voting rights threshold, reflecting their continued investment in...

Continue Reading